Interleukin-18 promoter polymorphisms and risk of ischemic stroke

Brain Research Bulletin

Volumn 81, Issue 6, 2010, Pages 590-594

  Zhang, Na ^a   Yu, Jin Tai ^a   Yu, Nan Nan ^a   Lu, Rui Chun ^a   Ma, Teng ^b   Wang, Nai Dong ^c   Miao, Dan ^a   Song, Jing Hui ^c   Tan, Lan ^a  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

^b Qingdao Hiser Hospital   (China)

^c Department of Neurology   (China)

Author keywords

Inflammation; Interleukin 18; Ischemic stroke; Polymorphisms

Indexed keywords

INTERLEUKIN 18;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-18; MALE; POINT MUTATION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK; STROKE;

EID: 76749089492     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.01.008     Document Type: Article

References (57)

1. Arimitsu J., Hirano T., Higa S., Kawai M., Naka T., Ogata A., Shima Y., Fujimoto M., Yamadori T., Hagiwara K., Ohgawara T., Kuwabara Y., Kawase I., and Tanaka T. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem. Biophys. Res. Commun. 342 (2006) 1413-1416
2. Bai J., Zhang Y., Lin M., Zeng X., Wang Z., Shen J., Jiang L., Gao F., and Chen Q. Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: a study in an ethnic Chinese cohort. Tissue Antigens 70 (2007) 390-397
3. Balding J., Livingstone W.J., Pittock S.J., Mynett-Johnson L., Ahern T., Hodgson A., and Smith O.P. The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir. J. Med. Sci. 173 (2004) 200-203
4. Banerjee I., Gupta V., Ahmed T., Faizaan M., Agarwal P., and Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res. Bull. 75 (2008) 158-165
5. Bis J.C., Heckbert S.R., Smith N.L., Reiner A.P., Rice K., Lumley T., Hindorff L.A., Marciante K.D., Enquobahrie D.A., Monks S.A., and Psaty B.M. Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis 198 (2008) 166-173
6. Bossù P., Ciaramella A., Moro M.L., Bellincampi L., Bernardini S., Federici G., Trequattrini A., Macciardi F., Spoletini I., Di Iulio F., Caltagirone C., and Spalletta G. Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 78 (2007) 807-811
7. Chandrasekar B., Mummidi S., Alente A.J., Patel D.N., Bailey S.R., Freeman G.L., Hatano M., Tokuhisa T., and Jensen L.E. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling. J. Biol. Chem. 280 (2005) 26263-26277
8. Dao T., Ohashi K., Kayano T., Kurimoto M., and Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol. 173 (1996) 230-235
9. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20 (2002) S1-S13
10. Excoffier L., Laval G., and Schneider S. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol. Bioinform. 1 (2005) 47-50
11. Falk R.H. Atrial fibrillation. N. Engl. J. Med. 344 (2001) 1067-1078
12. Felderhoff-Mueser U., Schmidt O.I., Oberholzer A., Bührer C., and Stahel P.F. IL-18: a key player in neuroinflammation and neurodegeneration?. Trends Neurosci. 28 (2005) 487-493
13. Finotto S., Siebler J., Hausding M., Schipp M., Wirtz S., Klein S., Protschka M., Doganci A., Lehr H.A., Trautwein C., Khosravi-Fahr R., Strand D., Lohse A., Galle P.R., Blessing M., and Neurath M.F. Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 53 (2004) 392-400
14. Flossmann E., Schulz U.G., and Rothwell P.M. Potential confounding by intermediate phenotypes in studies of the genetics of ischaemic stroke. Cerebrovasc. Dis. 19 (2005) 1-10
15. Giedraitis V., He B., Huang W.X., and Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J. Neuroimmunol. 112 (2001) 146-152
16. Gillespie M.T., and Horwood N.J. Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev. 9 (1998) 109-116
17. Gracie J.A., Koyama N., Murdoch J., Field M., McGarry F., Crilly A., Schobel A., Madhok R., Pons-Kühnemann J., McInnes I.B., and Möller B. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun. 6 (2005) 211-216
18. Gracie J.A., Robertson S.E., and McInnes I.B. Interleukin-18. J. Leukoc. Biol. 73 (2003) 213-224
19. Hillbom M., Numminen H., and Juvela S. Recent heavy drinking of alcohol and embolic stroke. Stroke 30 (1999) 2307-2312
20. Imboden M., Nicod L., Nieters A., Glaus E., Matyas G., Bircher A.J., Ackermann-Liebrich U., Berger W., Probst-Hensch N.M., and SAPALDIA Team. The common G-allele of interleukin-18 single-nucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort Study. Clin. Exp. Allergy 36 (2006) 211-218
21. Imboden M., Nieters A., Bircher A.J., Brutsche M., Becker N., Wjst M., Ackermann-Liebrich U., Berger W., Probst-Hensch N.M., and SAPALDIA Team. Cytokine gene polymorphisms and atopic disease in two European cohorts (ECRHS-Basel and SAPALDIA). Clin. Mol. Allergy 7 (2006) 4-9
22. Joosten L.A., Radstake T.R., Lubberts E., van den Bersselaar L.A., van Riel P.L., van Lent P.L., Barrera P., and van den Berg W.B. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 48 (2003) 339-347
23. Kalina U., Ballas K., Koyama N., Kauschat D., Miething C., Arnemann J., Martin H., Hoelzer D., and Ottmann O.G. Genomic organization and regulation of the human interleukin-18 gene. Scand. J. Immunol. 52 (2000) 525-530
24. Khripko O.P., Sennikova N.S., Lopatnikova J.A., Khripko J.I., Filipenko M.L., Khrapov E.A., Gelfgat E.L., Yakushenko E.V., Kozlov V.A., and Sennikov S.V. Association of single nucleotide polymorphisms in the IL-18 gene with production of IL-18 protein by mononuclear cells from healthy donors. Mediators Inflamm. 2008 (2008) 309721
25. Kim Y., and Lee C. The gene encoding transforming growth factorβ1confers risk of ischemic stroke and vascular dementia. Stroke 37 (2006) 2843-2845
26. Lee B.C., Ahn S.Y., Doo H.K., Yim S.V., Lee H.J., Jin S.Y., Hong S.J., Lee S.H., Kim S.D., Seo J.C., Leem K.H., and Chung J.H. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci. Lett. 357 (2004) 33-36
27. Li N., He Z., Xu J., Liu F., Deng S., and Zhang H. Association of PDE4D and IL-1 gene polymorphism with ischemic stroke in a Han Chinese population. Brain Res. Bull. 81 (2010) 38-42
28. Liang X.H., Cheung W., Heng C.K., and Wang D.Y. Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem. Biophys. Res. Commun. 338 (2005) 736-741
29. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
30. Liu W., Tang Q., Jiang H., Ding X., Liu Y., Zhu R., Tang Y., Li B., and Wei M. Promoter polymorphism of interleukin-18 in angiographically proven coronary artery disease. Angiology 60 (2009) 180-185
31. Mallat Z., Corbaz A., Scoazec A., Besnard S., Leseche G., Chvatchko Y., and Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104 (2001) 1598-1603
32. Mallat Z., Corbaz A., Scoazec A., Graber P., Alouani S., Esposito B., Humbert Y., Chvatchko Y., and Tedgui A. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ. Res. 89 (2001) E41-E45
33. Nakase T., Yamazaki T., Ogura N., Suzuki A., and Nagata K. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J. Neurol. Sci. 271 (2008) 104-109
34. Okamura H., Tsutsui H., Kashiwamura S., Yoshimoto T., and Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70 (1998) 281-312
35. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., and Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88-91
36. Pawlik A., Kurzawski M., Czerny B., Gawronska-Szklarz B., Drozdzik M., and Herczynska M. Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis. Tissue Antigens 67 (2006) 415-418
37. Pei F., Han Y., Zhang X., Yan C., Huang M., Huang L., and Kang J. Association of interleukin-18 gene promoter polymorphisms with risk of acute myocardial infarction in northern Chinese Han population. Clin. Chem. Lab. Med. 47 (2009) 523-529
38. Peters N.S., Schilling R.J., Kanagaratnam P., and Markides V. Atrial fibrillation: strategies to control, combat, and cure. Lancet 359 (2002) 593-603
39. Pratesi C., Bortolin M.T., Bidoli E., Tedeschi R., Vaccher E., Dolcetti R., Guidoboni M., Franchin G., Barzan L., Zanussi S., Caruso C., and De Paoli P. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol. Immunother. 55 (2006) 23-30
40. Rabkin S.W. The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease. Nat. Clin. Pract. Cardiovasc. Med. 6 (2009) 192-199
41. Revilla M., Obach V., Cervera A., Dávalos A., Castillo J., and Chamorro A. A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci. Lett. 324 (2002) 29-32
42. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
43. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98
44. Sivalingam S.P., Yoon K.H., Koh D.R., and Fong K.Y. Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens 62 (2003) 498-504
45. Thomassen E., Bird T.A., Renshaw B.R., Kennedy M.K., and Sims J.E. Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J. Interferon Cytokine Res. 18 (1998) 1077-1088
46. Tricot O., Mallat Z., Heymes C., Belmin J., Lesèche G., and Tedgui A. Relation between endothelial cell apoptosis and blood flow direction in human atheroscleroticp laques. Circulation 101 (2001) 2450-2453
47. Van der Wall A.C., Becker A.E., Van der Loos C.M., and Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994) 36-44
48. Vila N., Filella X., Deulofeu R., Ascaso C., Abellana R., and Chamorro A. Cytokine-induced inflammation and long-term stroke functional outcome. J. Neurol. Sci. 162 (1999) 185-188
49. Wang X., Cheng S., Brophy V.H., Erlich H.A., Mannhalter C., Berger K., Lalouschek W., Browner W.S., Shi Y., Ringelstein E.B., Kessler C., Luedemann J., Lindpaintner K., Liu L., Ridker P.M., Zee R.Y., and Cook N.R. RMS Stroke SNP Consortium. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 40 (2009) 683-695
50. Whitman S.C., Ravisankar P., and Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma. Circ. Res. 90 (2002) E34-E38
51. Wigginton J.E., Cutler D.J., and Abecasis1 G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76 (2005) 887-893
52. Yip H.K., Hung W.C., Yang C.H., Chen Y.H., Cheng C.I., Chen S.M., and Yeh K.H. Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting. Cir. J. 69 (2005) 1202-1207
53. Yip H.K., Sun C.K., Chang L.T., and Wu C.J. Strong correlation between serum levels of inflammatory mediators and their distribution in infarct-related coronary artery. Circ. J. 70 (2006) 838-845
54. Yu J.T., Tan L., Song J.H., Sun Y.P., Chen W., Miao D., and Tian Y. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Res. 1253 (2009) 169-175
55. Yuen C.M., Chiu C.A., Chang L.T., Liou C.W., Lu C.H., Youssef A.A., and Yip H.K. Level and value of interleukin-18 after acute ischemic stroke. Circ. J. 71 (2007) 1691-1696
56. Zaremba J., and Losy J. Interleukin-18 in acute ischaemic stroke patients. Neurol. Sci. 24 (2003) 117-124
57. Zhang P.A., Wu J.M., Li Y., and Yang X.S. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J. Gastroenterol. 11 (2005) 1594-1598